GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

Atara Biotherapeutics ATRA · USD

Health Care · US listing · 🇺🇸 United States

Compare

8.18

+3.94%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Latest on Atara Biotherapeutics

Our reporting

We have not reported on Atara Biotherapeutics yet.

Next results

11 Nov 2026

Due on 11 Nov 2026. Analysts expect earnings of -0.13 a share on revenue of $800,000.

Past results

Reported against what analysts expected

12 Aug 202614 May 202616 Mar 202612 Nov 202511 Aug 20257 Mar 2025
Earnings per share-0.32-0.29-0.25-0.320.19-1.19
Forecast-0.32-0.33-0.09-0.83-0.32-3.82
Revenue$630,000$516,000$1.6m$3.5m$17.6m$32.8m
Forecast$550,000$2.9m$3.4m$700,000$1.8m$20.6m

Key events

  1. 20 Jun 202425-to-1 reverse split
  2. 16 Oct 2014Listed

Atara Biotherapeutics in the news

Headlines from other publishers, linked to their own pages.

Sources and methodology

Data on this tab
Our reporting and our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.